Marinus Pharmaceuticals I... (MRNS)
undefined
undefined%
At close: undefined
0.25
-3.24%
Pre-market Dec 16, 2024, 04:27 AM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12
Revenue 30.99M 25.48M 15.35M 1.72M - - - - - - - 100.00K
Cost of Revenue 1.93M 340.00K 1.48M 50.51M 503.00K 127.00K 126.00K 23.00K 11.00K - - -
Gross Profit 29.05M 25.14M 13.87M -48.79M -503.00K -127.00K -126.00K -23.00K -11.00K - - 100.00K
Operating Income -131.49M -112.79M -96.93M -67.94M -54.42M -37.18M -19.04M -28.24M -24.43M -11.92M -5.38M -1.43M
Interest Income 8.11M 2.35M 80.00K 499.00K 354.00K 454.00K 324.00K 128.00K 64.00K 12.00K 19.05K 2.66K
Pretax Income -142.94M -16.43M -98.78M -67.47M -54.12M -36.73M -18.90M -28.64M -24.85M -10.83M -5.27M -1.41M
Net Income -141.41M -19.82M -101.66M -66.64M -53.77M -36.73M -18.90M -28.64M -24.85M -10.83M -5.27M -1.41M
Selling & General & Admin 61.15M 56.84M 37.28M 18.55M 11.46M 8.79M 6.67M 6.24M 5.52M 3.23M 1.23M 685.10K
Research & Development 99.39M 79.91M 73.52M 51.11M 42.97M 28.39M 12.38M 22.00M 18.92M 8.69M 4.15M 845.56K
Other Expenses - 1.17M 657.00K -37.00K -53.00K -1K -20.00K -65.00K -7.00K 1.19M 152.69K 336.05K
Operating Expenses 160.54M 137.93M 110.80M 69.66M 54.42M 37.18M 19.04M 28.24M 24.43M 11.92M 5.35M 1.53M
Interest Expense 16.89M 10.67M 2.58M - - - 159.00K 464.00K 475.00K 117.00K 90.61K 320.78K
Selling & Marketing Expenses - - - - - - - - - - - -
Cost & Expenses 162.47M 138.27M 112.28M 69.66M 54.42M 37.18M 19.04M 28.24M 24.43M 11.92M 5.35M 1.53M
Income Tax -1.54M 3.39M 2.88M -833.00K -354.00K 453.00K 13.00K 399.00K 468.00K 1.31M -27.82K 656.83K
Shares Outstanding (Basic) 53.75M 39.07M 36.70M 27.27M 13.63M 10.22M 5.89M 4.87M 3.73M 1.54M 2.02M 2.02M
Shares Outstanding (Diluted) 53.75M 39.07M 36.70M 27.27M 13.63M 10.22M 5.89M 4.87M 3.73M 1.54M 2.02M 2.02M
EPS (Basic) -2.63 -0.51 -2.77 -2.44 -3.95 -3.59 -3.21 -5.88 -6.66 -7.04 -2.61 -0.7
EPS (Diluted) -2.63 -0.51 -2.77 -2.44 -3.95 -3.59 -3.21 -5.88 -6.66 -7.04 -2.61 -0.7
EBITDA -125.50M -5.09M -95.53M -66.88M -54.42M -36.60M -18.61M -28.16M -24.36M -10.71M -5.20M -1.07M
Depreciation & Amortization 551.00K 669.00K 667.00K 598.00K 503.00K 127.00K 126.00K 23.00K 11.00K 5.00K 9.79K 17.90K